Clinical Trial Update: Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

View source ↗

Summary

Clinical trial update for a study on financial toxicity in patients with resected soft tissue and bone sarcomas; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft Tissue Sarcoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bone Sarcomas, Financial Toxicity | Status: RECRUITING